Shardul Amarchand Mangaldas & Co. advised Morgan Stanley PE Asia Fund (Morgan Stanley) on acquiring a minority stake in Hyderabad Institute of Oncology Private Limited (Company). The deal is valued approximately at INR 500 cr.
The Company operates a chain of hospitals (“Omega Hospitals”) focused on oncology and cancer treatment, across Telangana and Andhra Pradesh. Led by Dr. Mohan Vamsy, a leading surgical oncologist, Omega Hospitals is India’s second largest cancer-focused hospital chain.
The transaction team was led by Nivedita Tiwari, Partner; Kuhuk Jain, Principal Associate; Tweisha Mishra, Senior Associate; Anushka Ganguli, Associate and Tryambica Singh, Associate.
The due diligence team was led by Nivedita Tiwari, Partner; Devesh Pandey, Partner; Shruti Kinra, Partner; Alina Arora, Partner; Pooja Ramchandani, Partner; J .V. Abhay, Partner; Ashoo Gupta, Partner; Suruchi Kumar, Partner; Apurva Zutshi, Partner; Leoni Mahanta, Principal Associate; Tweisha Mishra, Senior Associate; Subhojit Das, Senior Associate; Lakshya Gupta, Senior Associate; Sai Dharshini Venkatesan, Senior Associate; Noaman Mujahed, Senior Associate; Sampada Naik, Senior Associate; Anushka Ganguli, Associate; Arjun Yadav, Associate; Garima Tripathi, Associate; Mragank Shukla, Associate; Mrinal Sharma, Associate; Priti Rasam, Associate; Mahinder Udasi, Associate and Sanskriti Nigam, Associate.
The competition team was led by Manika Brar, Partner; Shivek Sahai Endlaw, Associate and Rohan Bhargava, Associate.
Morgan Stanley was advised by PWC on the tax aspects.
The company and its promoters, Dr. Mohan Vamsy Chigurupati, Dr. Padmaja Chigurupati and Dr. Nagavardhanamma Parvathaneni were advised by J. Sagar Associates; Veda Corporate Advisors Private Limited and Transaction Square on the legal, financial and tax aspects respectively.
_20241005155221_original_image_28.webp)
_20241005140810_original_image_26.webp)
_20240801191347_original_image_31.webp)